Western biotechs ponder follow-on possibilities.
Waltz
Emily
E
D001709:Biotechnology / Q000191:economics / Q000331:legislation & jurisprudence / Q000639:trends*; D002170:Canada; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence / Q000639:trends*; D005060:Europe; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology; D006801:Humans; D011994:Recombinant Proteins; D014481:United States; D014486:United States Food and Drug Administration
D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000069585:Filgrastim